Download in electronic PDF format for $25



Search the Complete Journal Archives

Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings

Author(s):  Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy

Issue:  Mar/Apr 2013 - Volume 17, Number 2
View All Articles in Issue

Abstract:  The objective of this study was to establish benchmark rates for microbial and bacterial endotoxin contamination rates for radiopharmaceutical preparations compounded in commercial nuclear pharmacies. Radiopharmaceutical samples were obtained between November 2006 and June 2010 from seven commercial nuclear pharmacies. Preparations were compounded per the compounding protocols of each radiopharmacy, and each kit was used for unit-dose dispensing of patient-specific doses. Samples for testing were withdrawn after unit doses were dispensed. Sterility testing was performed on each radiopharmaceutical sample and incubated at appropriate temperatures for 14 days. A sample of the radiopharmaceutical was also used to complete limulus amebocyte lysate-based bacterial endotoxin testing. Over the course of the study, 1516 radiopharmaceutical samples from 16 different radiopharmaceutical preparations, including eluates from radionuclide generators, were tested for sterility and bacterial endotoxicity. For the sterility testing, 13 of the 1516 samples (0.86%) showed evidence of growth in the testing media, indicating the presence of microbes in the tested sample. For bacterial endotoxin testing, 4 of 1492 samples (0.27%) showed formation of gel clots, indicating the presence of bacterial endotoxins in the sample. The microbial and bacterial endotoxin contamination rates of aseptically compounded radiopharmaceuticals compounded in a commercial nuclear pharmacy environment are extremely low. The results of this study show the high level of safety and quality that is provided when obtaining radiopharmaceutical doses that are compounded and dispensed from a commercial nuclear pharmacy.

Related Keywords: Kara D. Weatherman, PharmD, BCNP, FAPhA, Samuel Augustine, PharmD, FAPhA, Jeffrey Christoff, PhD, Wendy Galbraith, PharmD, BNCP, microbial contamination, bacterial endotoxins, radiopharmaceuticals, nuclear pharmacy, nuclear medicine, compounded sterile preparations, drug safety, United States Pharmacopeia Chapter <797>, USP

Related Categories: NUCLEAR, PARENTERALS, PEER-REVIEWED, STERILE PREPARATIONS, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy Mar/Apr 2013 168-174 Buy
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy May/Jun 2013 238-246 Buy
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy Galbraith Wendy, Shadid Jill May/Jun 2012 253-256 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, LlambĂ­ Francesc Jan/Feb 2014 6-12 Buy
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Cooper James F Jan/Feb 2011 49-54 Buy
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Dawson Michael E Jul/Aug 2010 317-320 Buy
Compounding for Diabetic Patients:An Interview with Paul Lofholm, PharmD Allen Loyd V Jr Nov/Dec 1997 381-385 Buy
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Dawson Michael F Jan/Feb 2006 36-39 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181 Buy
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand Mar/Apr 2016 148-154 Buy